Clinical analysis of nasopharyngeal cancer

From 2005, nasopharyngeal cancer (NPC) patients were treated with concurrent chemoradiotherapy (CCRT) as the initial treatment in our department. We evaluated the effect of CCRT at two months after completion of treatment and added cyberknife treatment for the patients with the exception of complete response cases. For the distant metastasis case, we aggressively administered local treatment such as surgery and radiofrequency wave cauterization therapy. Nineteen nasopharyngeal cancer patients treated with CCRT in our hospital between 2005 and 2010 were analyzed retrospectively. The response rate of the initial treatment with CCRT was 94.7%, and the 3-year survival rate of all cases was 92.9%. We have sequentially accumulated cases treated with the current treatment strategy and are going to perform a repeat examination. (author)